Summary
M2 EQUITYBITES-May 31, 2011-Evotec announces Boehringer Ingelheim commencement of Phase I clinical trial for treatment of neuropathic pain and receipt of milestone payment of EUR2m
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Milestone Payment of Eur2m
Drug discovery alliance and development partnership co...
See the full content of this document
Sponsored links
